CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-Label, Fixed-Sequence, Drug Interaction Study to Investigate the Effect of Once-Weekly Rifapentine and Isoniazid on the Pharmacokinetics of Steady-State Doravirine

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03886701
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:45.953853+00:00
Published At: 2020-03-03T00:00:00+00:00
Record Updated At: 2020-03-27
Results Posted At: 2020-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Latent Tuberculosis", "Human Immunodeficiency Virus", "Rifamycins Causing Adverse Effects in Therapeutic Use", "Drug Interaction Potentiation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-03-27"
protocolSection.identificationModule.nctId: "NCT03886701"
protocolSection.identificationModule.officialTitle: "A Phase 1, Open-Label, Fixed-Sequence, Drug Interaction Study to Investigate the Effect of Once-Weekly Rifapentine and Isoniazid on the Pharmacokinetics of Steady-State Doravirine"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-03-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.